NCI National Clinical Trials Network (NCTN) Program Guidelines
NCI National Clinical Trials Network (NCTN) Program Guidelines
NCI National Clinical Trials Network (NCTN) Program Guidelines
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PART 1: Overview of <strong>NCTN</strong> <strong>Program</strong> Section IV – Terms/Conditions of Award – Joint Responsibilities<br />
� <strong>NCTN</strong> Regulatory Support Services (RSS) via the Cancer <strong>Trials</strong> Support Unit (CTSU)<br />
� <strong>NCTN</strong> Specification for appropriate designation of per case funding for trials prior to activation<br />
� <strong>NCI</strong> CIRB Review for studies as required under these <strong>Guidelines</strong><br />
6. Legacy Studies<br />
Legacy studies supported by the <strong>NCTN</strong> <strong>Program</strong> will be conducted under the same <strong>NCTN</strong> Terms and<br />
Conditions of Award as are those studies that commence under the <strong>NCTN</strong> <strong>Program</strong>. Hence, the awardees<br />
of any of the key components of the <strong>NCTN</strong> <strong>Program</strong> (i.e., <strong>Network</strong> Group Operations Centers, <strong>Network</strong><br />
Group Statistics and Data Management Centers, <strong>Network</strong> Integrated Translational Science Awards, <strong>Network</strong><br />
Lead Academic Participating Sites, <strong>Network</strong> Radiotherapy and Imaging Core Services Centers, and Canadian<br />
Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong>) are bound by the Terms and Conditions of their Award under the<br />
<strong>NCTN</strong> <strong>Program</strong> when working on legacy studies that are supported by the <strong>NCTN</strong> <strong>Program</strong>.<br />
Page 90 of 241
Change language